A group of researchers were tasked with investigating the association of phytocannabinoids and migraine.
Read in Spanish
A cannabis extract containing 100 mg / ml of CBD and 2 mg / ml of THC reduced the number of seizures in a study conducted with 19 children with Dravet Syndrome, a serious disease of epilepsy.
The research was carried out at the Hospital for Sick Children in Toronto, where the analysis of the operation of the regular treatment was made in conjunction with an alternative medicinal cannabis.
Both Δ9 Tetrahydrocannabinol (THC) and cannabidiol (CBD) have been shown to have antiepileptic effects. The oils extracted from this plant are used effectively to treat epilepsy in cases where there is resistance to pharmaceutical drugs.
The average daily dose reached was 13.3 mg / kg of CBD (range: 7 to 16 mg / kg of weight) and 0.27 mg / kg of THC (range: 0.14 to 0.32 mg / kg of weight).
"There was a statistically significant improvement in quality of life, a reduction in peak activity of the EEG and a reduction in the mean of motor seizures of 70.6%," the study authors note.
Some adverse effects experienced during the assessment were drowsiness, diarrhea and anorexia, although the causes are not exactly specified.
The investigation concludes that the concentrate prepared with CBD and THC was found to be effective and safe in the 19 children.
"TIL-TC150 (name of the concentrate) was effective in reducing seizures and improving the quality of life," the study notes.
The study also achieves another of its stated objectives in the conclusions: to provide safe information for the dosing of cannabis preparations containing THC.
Read the full study at this link: https://bit.ly/2CDIoVL
Follow us on Instagram: @mcnglobal